The studies were undertaken to determine whether isoflurane inhalation is associated with a degree of beta-adrenergic action that is potentially important in clinical situations, and to compare the circulatory tolerance to isoflurane and halothane in dogs following beta blockade. We measured arterial and pulmonary artery pressure, left and right ventricular rilling pressure, heart rate and cardiac output, and derived stroke volume and systemic and pulmonary vascular resistances in 13 mongrel dogs. The haemodynamic response to 1 MAC and 2 MAC isoflurane was studied in seven dogs and was similar before and after propranolol 0.1 mg/kg i.v. In six dogs, propranolol 0.5 mg/kg caused no significant changes in the circulatory response to 1 MAC and 2 MAC isoflurane or 1 MAC halothane. However, in three dogs, administration of 2 MAC halothane after propranolol 0.5 mg/kg resulted in such profound circulatory depression as to preclude further study. These data suggest that (a) isoflurane possesses no clinically important beta-adrenergic stimulating activity; (b) there is no adverse drug interaction upon the circulation with the combination of isoflurane and propranolol; (c) in the presence of moderate to profound beta-adrenergic blockade, 2 MAC isoflurane may be tolerated better than 2 MAC halothane.
The anaesthetic management of patients receiving beta-adrenergic blocking drugs for relief of angina pectoris is controversial (Merin, 1972) . If therapy is discontinued before induction of anaesthesia, myocardial oxygen demand and supply may become unbalanced, leading to myocardial ischaemia. According to Miller and colleagues (1975) , six of 20 patients sustained either a life-threatening or a fatal cardiac incident (including ventricular tachycardia, fatal myocardial infarction and sudden death) within 2 weeks after abrupt withdrawal of beta-adrenergic blockade produced by 160-320 mg of propranolol daily. Viljoen, Estafanous and Kellner (1972) advised that a 2-week interval be mandatory between the last dose of propranolol and administration of anaesthesia on the basis of a series of five fatalities occurring in the presence of "profound" beta-adrenergic blockade. In contrast, Prys-Roberts and others (1973) have recommended administration of beta-adrenergic blockers immediately before anaesthesia, since they demonstrated a dramatic decrease in the incidence of ischaemic e.c.g. changes during induction of anaesthesia and tracheal intubation in hypertensive patients pretreated with practolol, a cardioselective betaadrenergic blocking agent.
Since increasing numbers of patients are receiving beta-adrenergic blocking agents (Pitt and Ross, 1969; Johnstone, 1970; Miller, Amsterdam and Mason, 1975) , it has become important to know if an anaesthetic agent possesses a beta-adrenergic stimulating action of any clinical significance and whether the anaesthetic agent is tolerated in the presence of betaadrenergic blockade. Stevens and co-workers (1971) have suggested that some of the haemodynamic effects of isoflurane are consistent with beta-adrenergic stimulation. In our previous study (Philbin and Lowenstein, 1975) we were unable to demonstrate any central beta-adrenergic effect of 1 MAC isoflurane inhalation in the presence of profound beta blockade produced by propranolol 0.5 mg/kg in the dog, and the evidence for a peripheral beta-adrenergic action was not compelling. The primary purpose of these studies was to determine if a beta-adrenergic action of isoflurane could be demonstrated at greater concentrations of isoflurane or during less profound blockade, or both, and to compare the effect of halothane and isoflurane in the presence of betaadrenergic blockade. In addition, we wished to exclude the possibility that chloralose-urethane basal anaesthesia had been responsible for our previous findings.
METHODS
Thirteen healthy mongrel dogs weighing between 18 kg and 22 kg were divided arbitrarily into two groups. In group I (« = 7) basal anaesthesia was provided by sodium thiopentone 10 mg/kg i.v. The trachea was intubated with a wide-bore-cuffed tube and the dog was ventilated with 1.5% isoflurane in oxygen using a non-rebreathing system via a Harvard animal respirator. In group II (« = 6) basal anaesthesia was provided by the inhalation of 0.85% halothane (~1 MAC) (Eger et al., 1965) , using oxygen as the carrier gas.
Polyethylene catheters for monitoring and sampling were introduced into the abdominal aorta via the femoral artery, and into the right atrium via the jugular vein, and a balloon-tipped flow-directed catheter was introduced into the pulmonary artery (Swan et al., 1970) . Systemic arterial (AP) and pulmonary artery (PA) pressure, right atrial pressure (RAP) and pulmonary capillary wedge pressure (PCW) were measured using a transducer and recorded on a Hewlett-Packard recorder. The heart rate was calculated from the e.c.g.
End-tidal isoflurane and halothane concentrations were measured using a Beckman LB-2 infra-red gas analyser. Cardiac output was determined by indicatordilution using cardiogreen dye and a Gilford densitometer with pulmonary artery injection and sampling from the catheter in the abdominal aorta. Pa 02 , Pa C02 and pHa were measured by standard polarographic techniques.
Systemic and pulmonary vascular resistances and stroke volume were calculated according to the following formulae (Yang, Bentivoglio and Maranhao, 1972) : (mmHg) SV = stroke volume (ml/beat) HR = heart rate (beat/min) CO = cardiac output (litre/min) Data were analysed by Student's t test. A P value of less than 0.05 was considered significant.
The procedure for these studies is shown in table I. Group I. Initial measurements (period I) were obtained at a concentration of 1.5% isoflurane at a minimum of 1 h after administration of thiopentone. (Joas and Stevens (1971) have obtained a MAC value of 1.46 + 0.25% in the dog.) The concentration of isoflurane was then increased to 2 MAC (3%) and the measurements were repeated (period II). The concentration was reduced to 1 MAC and a third set of measurements was obtained (period III). Propranolol 0.1 mg/kg i.v. was then administered and measurements were made at 1 MAC, 2 MAC and 1 MAC isoflurane (periods IV-VI).
Group II. Measurements were obtained at 1 MAC halothane (period I) and then at 1 MAC isoflurane (period II). Propranolol 0.5 mg/kg i.v. was administered and the measurements were repeated at 1 MAC halothane (period III), then 1 MAC, 2 MAC and 1 MAC isoflurane (periods IV-VI). After the administration of propranolol, beta blockade was confirmed by the absence of a haemodynamic response to isoproterenol 2 ;xg injected as a bolus. A minimum of 20 min of a given concentration of anaesthetic was administered in both groups before measurements were performed. Table II presents the haemodynamic data from group I. Before the administration of propranolol, 2 MAC isoflurane (period II) was associated with a significant decrease in mean arterial pressure (P<0.01), CO (P<0.05), stroke volume (P<0.05) and systemic vascular resistance (P<0.05) when compared with 1 MAC isoflurane. The values obtained after administration of propranolol 0.1 mg/kg at 1 MAC and 2 MAC isoflurane were similar (P>0.2) to those obtained before blockade, that is periods I and III were similar to periods IV and VI, and period II was similar to period V. Table III contains the data for group II. Isoflurane 1 MAC, compared with halothane 1 MAC, was associated with a slightly faster heart rate, a larger CO and a smaller SVR. These differences did not achieve statistical significance (P>0.10). The administration of propranolol 0.5 mg/kg produced no significant change in any of the haemodynamic parameters measured at either 1 MAC halothane (period III) or 1 MAC isoflurane (periods IV and VI). The data obtained in period V (isoflurane 2 MAC + propranolol 0.5 mg/kg) did not differ significantly from those obtained in group I at 2 MAC isoflurane before or after propranolol administration (table II, periods II and V, and fig. 1 ).
In both groups mean Pa C02 in all periods ranged from 26 mm Hg to 31 mm Hg, the mean pHa from 7.40 units to 7.42 units and the mean Pa Oa from 483 mm Hg to 506 mm Hg. No significant changes occurred in any of these measurements at any time during the study. The observed differences are small and did not reach statistical significance for any parameter. CO = cardiac output; AP = mean systemic arterial pressure; SVR = systemic vascular resistance; HR = heart rate; PCW = mean pulmonary capillary wedge pressure; bpm = beat/min.
DISCUSSION
The most important finding in this study is that the circulatory response of the dog to 1 MAC or 2 MAC isoflurane is not influenced by the i.v. administration of propranolol 0.1 mg/kg or 0.5 mg/kg. The results suggest also that there is no clinically important betaadrenergic action of isoflurane. The administration of propranolol did not affect the heart rate; this was not unexpected, since Shell and Sobell (1973) reported that as much as 2 mg/kg may be necessary to produce a change in rate in the dog. That our data signify a response to isoflurane, and are not dependent upon a specific pretreatment, is suggested by the similarity of the responses to isoflurane in group I (thiopentone induction), group II (halothane induction) and our previous study (chloralose-urethane basal anaesthesia) (Philbin and Lowenstein, 1975) . In group II, the administration of propranolol 0.5 mg/kg did not change the circulatory response to 1 MAC halothane or 1 MAC isoflurane. Neither drug caused changes suggestive of beta-adrenergic stimulation. When the isoflurane concentration was increased to 2 MAC, the decrease in arterial pressure and CO was of the same magnitude as in group I, although the dose of propranolol was increased fivefold ( fig. 1) . In three animals of group II a halothane concentration of 2 MAC was administered following period VI. The ensuing circulatory depression was so profound as to preclude further study. This preliminary evidence suggests that, in the presence of profound beta-adrenergic blockade, deep isoflurane anaesthesia may be tolerated better than deep halothane anaesthesia. Saner and colleagues (1975) have recently demonstrated profound circulatory depression when beta-adrenergic blockade was established by practolol administration in dogs receiving 0.4% methoxyflurane. Thus there may be a range of circulatory tolerances to different anaesthetic agents in the presence of beta-adrenergic blockade.
While our use of intact, anaesthetized dogs does not allow us to exclude beta-adrenergic action following isoflurane, such an action would appear unlikely. If it is present, it is hard to conceive of circumstances in which it would be of any clinical significance.
en situaciones clinicas, y para comparer la tolerancia circulatona al isoflurano y halotano en los perros, tras un bloqueo-beta. Medimos las tensiones arterial y arteropulmonar, la presi6n ventricular de replecidn izquierda y derecha, frecuencia y gasto cardiacos, y descarga sistdlica derivada y resistencias vascular pulmonar y generalizada en 13 perros cruzados. La respuesta hemodinamica a 1 CAM (concentration alveolar minima) o 2 CAM de isoflurano fue estudiada en siete perros y fue similar antes y despues de 0,1 mg/kg de propranolol endovenosamente. En seis perros, 0,5 mg/kg propranolol no causo cambios significativos en la respuesta circulatoria a isoflurano 1 CAM y 2 CAM o halotano 1 CAM. Sin embargo, en tres perros, la administration de halotano 2 CAM tras 0,5 mg/kg propranolol resulto en una depresi6n circulatoria tan profunda que impidio cualquier nuevo estudio. Estos datos sugieren que (a) el isoflurano carece de cualquier actividad estimulante beta-adrenergica de importancia clinica; (b) no hay ninguna interaction medicamentosa adversa sobre la circulation de isoflurano y propanolol; (c) en presencia de bloqueo beta-adrenergico moderando a profundo, isoflurano 2 CAM pudiera ser mejor tolerado que halotano 2 CAM.
